This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

McCann Health Wins Most Clio Healthcare Awards

Stocks in this article: IPG

NEW YORK, Nov. 14, 2012 /PRNewswire/ -- McCann Health, winning a Gold and 4 Bronze awards, won the most metals at the Clio Healthcare Awards ceremony in New York City Tuesday night, reports Jeremy Perrott, Global Creative Director for McCann Health.

Comments Jeremy: "One thousand entries in this year's Clio Healthcare Awards from around the world made for a very strong show. We are only recognizing the 'metal' winners - being deliberately tough on ourselves, raising our own standards as we strive to be the best in our industry.

"This year we have had a very encouraging result. Only 6 Gold awards in the whole show and we won one of them. Then 4 Bronze statues.

"Congratulations to all agencies who won finalists and a huge hand for the state winners.

"These awards are becoming more and more difficult to win as the global standard becomes higher and higher. A direct result from the brilliant work being produced.

"Please congratulate:

  • McCann Torre Lazur London: Gold for its brilliant Erbitux film, and two Bronze statues– one for Cancer Screening and the other for Mundipharma.
  • McCann HumanCare NY: a Bronze for Tradjenta.
  • And McCann Health Sydney: a Bronze for innovative development and use of our corporate business card.

"A fantastic result."

 McCann Health CEO John Cahill said: "This success further cements McCann Health's position as the most creatively awarded network agency in health and wellness worldwide."

Phil Bartlett, Managing Director of McCann Health London added: "We're extremely proud of our achievements here - these awards show that we're doing the right things in the right ways, following through our creative vision from planning right through to production. The team here never stop pushing themselves and each other to bigger and better things and are a credit to the agency and the network."

Andrew Schirmer, Managing Director of McCann HumanCare, said: "When trying to support people with type 2 diabetes, it is critical to engage and entertain as you educate.  The animation/illustration and the first-person voice made this approach to patient education perfect for this brand, the client and obviously the Clio judges as this was the only winner in the Online Video category."

Amar Urhkar, President, MH Japan, and EVP, McCann Health Asia Pacific, said, "McCann Health Sydney continues to be the shining star in terms of the accolades and award win in Australia and internationally – kudos to the team for this consistent and spectacular performance ."

About McCann Health : Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. McCann Health's global network includes McCann HumanCare, McCann Healthcare, McCann Regan Campbell Ward, McCann Torre Lazur-- as well as the leading worldwide medical communications and consultancy practice, McCann Complete Medical. McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by Interpublic Group [NYSE: IPG].

SOURCE McCann Health

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs